Javier Pinilla, MD, PhD explores evidence on molecular mechanisms leading to resistance in second-generation BTK inhibitors for CLL, providing insights from recently presented data at ASH 2023.
Video Player is loading.
Play Video
Play
Mute
Current Time 0:00
/
Duration 7:26
Loaded: 0.00%
0:00
Stream Type LIVE
Seek to live, currently behind liveLIVE
Remaining Time -7:26
1x
Playback Rate
2x
1.75x
1.5x
1.25x
1x, selected
0.75x
0.5x
Chapters
Chapters
Descriptions
descriptions off, selected
Captions
captions settings, opens captions settings dialog
captions off, selected
Audio Track
en (Main), selected
Fullscreen
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
Reset restore all settings to the default valuesDone
Close Modal Dialog
End of dialog window.
Close Modal Dialog
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.